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Abstract
Endometriosis is an enigmatic painful disorder whose pain symptoms remain difficult to alleviate in large part because the
disorder is defined by extrauteral endometrial growths whose contribution to pain is poorly understood. A rat model
(ENDO) involves autotransplanting on abdominal arteries uterine segments that grow into vascularized cysts that become
innervated with sensory and sympathetic fibers. ENDO rats exhibit vaginal hyperalgesia. We used behavioral, physiological,
and immunohistochemical methods to test the hypothesis that cyst innervation contributes to the development of this
hyperalgesia after transplant. Rudimentary sensory and sympathetic innervation appeared in the cysts at two weeks,
sprouted further and more densely into the cyst wall by four weeks, and matured by six weeks post-transplant. Sensory
fibers became abnormally functionally active between two and three weeks post-transplant, remaining active thereafter.
Vaginal hyperalgesia became significant between four and five weeks post-transplant, and stabilized after six to eight
weeks. Removing cysts before they acquired functional innervation prevented vaginal hyperalgesia from developing,
whereas sham cyst removal did not. Thus, abnormally-active innervation of ectopic growths occurs before hyperalgesia
develops, supporting the hypothesis. These findings suggest that painful endometriosis can be classified as a mixed
inflammatory/neuropathic pain condition, which opens new avenues for pain relief. The findings also have implications
beyond endometriosis by suggesting that functionality of any transplanted tissue can be influenced by the innervation it
acquires.
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Introduction
Endometriosis is a painful disorder defined by extrauteral
endometrial growths [1–3]. Pains include severe dysmenorrhea,
dyspareunia (vaginal hyperalgesia), and chronic pelvic pain.
Endometriosis often co-occurs with other painful disorders such
as interstitial cystitis/painful bladder syndrome, irritable bowel
syndrome, migraine and other headaches, and more. Most
gynecologists characterize endometriosis as an ‘‘enigma,’’ mainly
because pain symptoms are unrelated to the amount of ectopic
growth, and the pain is difficult to treat. New approaches are badly
needed. Although about ten years ago it had been noted that pain
can be more severe in patients whose ectopic growths are located
near or in richly innervated anatomical sites (rectovaginal septum,
uterosacral ligaments) than in patients whose growths invaded less
densely innervated tissue (peritoneum and/or ovaries) [4,5], scant
attention was paid to this finding regarding nerves; research and
drug development remained focused on the ectopic growths and
their immediate external environment (e.g., peritoneal fluid and
local inflammation) as the source of the pain.
A rat model of endometriosis is created by autotransplanting on
abdominal arteries small pieces of uterus (ENDO). These
transplants become vascularized and form cysts [6]. As a control,
small pieces of fat are similarly autotransplanted (shamENDO),
but no cysts form. As in women with endometriosis, rats with
established ENDO (but not shamENDO) exhibit vaginal hyper-
algesia [7], and the amount of cystic growth does not correlate
with hyperalgesic severity [8,9].
Our group discovered that ectopic growths harvested from
ENDO rats and women with established endometriosis develop
their own C-fiber (sensory afferent) and sympathetic (autonomic
efferent) nerve supply. The supply is derived from nerve fibers
innervating nearby territories that sprout branches into the
growths [10,11]. This discovery suggests that, rather than the
growths alone, it is the ectopic growth’s own innervation that is a
major contributor to the maintenance and modulation of pain in
established endometriosis [12]. It remains unknown, however,
whether this sprouted and thereby abnormal innervation
contributes to the initial development of endometriosis-associated
pain. If so, painful endometriosis, now recognized as an
inflammatory condition [3], could also be considered within the
realm of neural dysfunction, i.e., a mixed inflammatory and
neurogenic pain, which would alter clinical approaches to the
pain.
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fibers sprouting into the transplants after surgery underlie the
development of vaginal hyperalgesia. If so, the time course of
development of abnormally functioning innervation should
precede and then parallel development of the hyperalgesia.
Furthermore, removal of the cysts before significant hyperalgesia
and stable innervation develops should prevent the hyperalgesia
from occurring. These predictions were tested in four studies.
Behavioral and immunohistochemical methods were used to
assess, respectively, the time course of development of vaginal
hyperalgesia and the cysts’ sensory and sympathetic innervation
after transplant surgery. To determine when the nerve fibers
become abnormally functionally active after they appear in the
cysts, the extravasation of Evans Blue dye (EB) was assessed in
nerve-intact compared with denervated cysts at different times
after transplant. This method relies on the fact that activity of C-
fibers produces the neurogenic contribution to EB extravasation
[13] and that activity in sympathetic fibers can also contribute
[14]. Therefore, abnormal nerve fiber activity in the cysts is
indicated when denervation reduces EB extravasation. Finally,
behavioral methods were used to assess the effects of removing the
cysts before they acquired functional innervation on transplant-
induced vaginal hyperalgesia. Our findings strongly support the
hypothesis that the invasion of the cysts by sensory and
sympathetic fibers is a major contributor to the development of
endometriosis-associated pain, which suggests an aggressive
clinical strategy of prevention.
Results
Vaginal hyperalgesia develops four weeks post-
transplant and stabilizes six to eight weeks post-
transplant
From one to three weeks after transplant surgery, the
probability of escape responses to vaginal distention did not differ
significantly from baseline responses; i.e., no significant changes
from baseline nociception had occurred (Fig. 1A). By four weeks
after transplant surgery, however, responses tended to differ from
baseline, becoming significantly different by five weeks. The
hyperalgesia then increased to stabilize after 6 weeks.
Sensory and sympathetic innervation of the cysts
appears two weeks post-transplant and attains mature
appearance by six weeks post-transplant (Figure 1B)
Immunofluorescence staining with antibodies to CGRP and
VMAT2 revealed that both sensory and sympathetic neurites first
appeared inside cysts two weeks post-transplant surgery; i.e., none
were observed inside cysts harvested one week after transplant.
The neurites at two weeks post-transplant were observed around
blood vessels entering the hilus at the outer wall of the cysts, and
had a rudimentary, mostly punctate appearance. By four weeks
post-transplant, the characteristics of both sensory and sympa-
thetic neurites changed their appearance so that they were no
longer punctate, but instead branched and looked similar to fibers
in established cysts. In addition, the fiber density increased
dramatically and populated the entire cyst wall, including
myometrial and endothelial layers. Both types of fibers were
densest in the hilus area. By six weeks after transplant, the
appearance of both types of fibers was similar to that at four weeks,
with a slight increase in density and similar to that at ten weeks
post-transplant. Overall, fiber characteristics at six weeks post-
transplant were virtually identical to those previously observed in
established cysts [10].
Cyst innervation becomes functional approximately
three weeks post-transplant (Figure 2)
EB dye extravasation into intact cysts increased progressively
after transplant surgery (F5,67=2.90, p=0.02) and became
significantly different at four weeks post-transplant surgery
compared with one week post-transplant (p,0.05). To estimate
when neurogenic activity contributed to this extravasation, the
extravasation in intact cysts was compared with the extravasation
in cysts that had been denervated before the dye was injected. In
other words, a neurogenic component would be revealed when
denervation produced a reduction in extravasation. Of importance
is that, whereas there was a gradual increase in dye extravasation
in the intact cysts, there were no significant differences over time
after transplant surgery in the denervated cysts (F5,65=0.77,
P=0.57). The differences between the intact and denervated cysts
became significant three weeks after transplant surgery, and
remained that way through ten weeks after transplant. In other
words, sensory fibers became abnormally active (produced
neurogenic activity) approximately three weeks after surgery.
Removing cysts before cyst innervation becomes active,
but not sham cyst removal, prevents subsequent
hyperalgesia from developing
Figure 3 shows the effects of cyst removal or sham cyst removal
during the 4 week period after transplant (when the cysts are being
invested with nerve fibers) on the subsequent development of
hyperalgesia. Overall, when cysts were removed any time during
this period (n=8), significant vaginal hyperalgesia failed to develop
(F1,14=0.68, P=0.80). This overall failure occurred either when
cysts were removed two weeks or less after transplant surgery
(Fig. 3B, n=3; [F1,8=0.28, P=0.61]) or when cysts were removed
later at 4 weeks after transplant surgery (Fig. 3C; [F1,4=0.43,
P=0.55]), although one of the 3 rats in this later group did exhibit
hyperalgesia. In contrast, when a sham cyst-removal surgery was
performed from 2–4 weeks post-transplant time in a different
group of rats, significant vaginal hyperalgesia developed in all rats
regardless of when the sham-cyst removal surgery had been done
(Fig. 3D, n=4; [F1,6=27.1, P=0.002]).
Discussion
Our studies show that a three-part sequence of events occurs
after transplant surgery in the rat model. Initially, two weeks after
transplant, the endometrial cysts acquire a rudimentary sensory
and sympathetic innervation. A week later, three weeks post-
transplant, this abnormal innervation becomes functional; i.e., it is
capable of contributing to neurogenic inflammation. By four to
five weeks, at which time the cysts are populated by sensory and
sympathetic nerve fibers, the hyperalgesia becomes significant.
Finally, removing the cysts before they acquire functional
innervation prevents the hyperalgesia from developing, whereas
a sham surgery does not. These results provide strong support for
the hypothesis that the cysts’ sensory and sympathetic innervation
underlies the development of vaginal hyperalgesia after transplant
surgery.
These findings relate to previous studies in the rat model that
indirectly suggest that, after the cysts stabilize, their sensory and
sympathetic innervation influences the severity of transplant-
associated hyperalgesia. Thus, it was found that, after the cysts
have stabilized (i.e., more than 8 weeks post-transplant), vaginal
nociception varies with estrous stage, with hyperalgesia present in
proestrus but absent the next day in estrus [7]. Later, it was found
that, at that .8 week post- transplant time, there are parallel
proestrous-to-estrous reductions in both the density of the cyst’s
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that likely affect activity of sensory C-fibers [15]. Similarly, at that
time, when a failure to remove all cysts during surgery produces an
increase in hyperalgesia, that increase is accompanied by an
increase in the density of sympathetic fibers in the cysts [9].
Together, these previous and our current results indicate that
there is a continuous and, importantly, a changing role of sensory
and sympathetic innervation of the cysts. Initially the innervation
contributes to the development of transplant-induced vaginal
hyperalgesia. Later, after the innervation is established, the
innervation contributes to modulation of its severity. Although
there are no clinical data yet available that address the former
component (neural sprouting into ectopic growths during early
stages of pain development), evidence is accumulating in women to
support the latter component (neural modulation of pain once
endometriosis is established) [12,16].
Here we showed in the rat that sprouting of C-fibers and
sympathetic fibers occurs in response to the initial pathology of the
transplants. Such sprouting is known to be associated with an
increase in the background and evoked activity of these fibers; that
is, fibers that develop sprouts become sensitized [17,18], which
contributes to protein extravasation [13]. This increased nocicep-
tive activity in turn produces changes in the excitability of spinal
neurons, a phenomenon called central sensitization [19,20], which
can expand from spinal segments where the fibers enter to more
remote regions [21]. In other words, the initial neural pathophys-
iology (sprouting and abnormal nerve activity) triggered by the
ectopic growths can, over time, induce central sensitization,
leading to chronic pain and co-morbidity [20]. Importantly,
central sensitization can eventually become self-sustained and
independent of peripheral pathology so that, in some women with
endometriosis, surgical removal of the ectopic growths would fail
to alleviate pain [3].
Insofar as data in rats can help us understand mechanisms that
contribute to pain in women with endometriosis (see table IV in
ref. 3), our findings here suggest that painful endometriosis in
women, already considered an inflammatory condition [3], might
benefit from being additionally classified as a neuropathic pain
Figure 1. A behavioral study of the development of vaginal hyperalgesia and an immunohistochemical study of the development
of cyst innervation after transplant surgery. Note that sensory and sympathetic fibers appear within the cysts two weeks before significant
hyperalgesia develops. A. Hyperalgesic severity (post-transplant AUC minus baseline AUC) at different times after transplant surgery in the same rats.
Error bars are 6 SEM (n=18). *, differs from two weeks; #, differs from six weeks, p,0.05. For the 4 week time point, *t=0.058. B. Photomicrographs
of sensory (CGRP-positive and sympathetic (VMAT2-positive) fibers in the cysts labeled at two, four, six, and ten weeks after transplant surgery (n=3–
5 rats/survival time). Calibration bar is 50 mm for all images.
doi:10.1371/journal.pone.0031758.g001
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the International Association for the Study of Pain as ‘‘pain caused
by a lesion or disease of the somatosensory nervous system’’ (http://
www.iasp-pain.org/AM/Template.cfm?Section=Pain_Defi…isplay.
cfm&ContentID=1728#Neuropathicpain, accessed October 12,
2011). Although a neuropathic pain classification is usually applied
to painful skin or musculoskeletal conditions that involve direct
damage to peripheral or central neural structures, it has been
argued that visceral C-fibers that are sensitized in association with
an initial inflammation ‘‘may become a source of neuropathic pain’’
[22]. Thus, for example, a neuropathic classification has recently
been effectively applied to pain associated with visceral disorders
such as pancreatitis, in which abnormal nerve sprouting, like that
associated with endometriosis, plays a substantial role in the
development of pain [23].
Our findings here clearly put an emphasis on prevention.
There is an astonishingly high prevalence of up to 90% of
adolescent girls who suffer from dysmenorrhea, with 15–20%
reporting it as severe [24–26]. A significant portiono ft h i sl a t t e r
group is likely to have endometriosis [3]. Recent brain imaging
studies have shown that moderate-to-severe dysmenorrhea is
associated with significant brain dysfunction and abnormalities
in the hypothalamic–pituitary–adrenal (HPA) axis (a reduction
in cortisol levels) [3,27–30]. Furthermore, and importantly,
these same studies also show that the longer the history of the
pain, the more severe the effects on the brain and the HPA axis.
Thus, one immediate consequence of reframing endometriosis
as a neuropathic/inflammatory pain condition would be to
reinforce the urgency of developing strategies for earlier
diagnosis of endometriosis [30,31] as well as treatment of its
associated pain (e.g., dysmenorrhea) before that pain can
become chronic and other painful co-morbid conditions arise.
Such classification would also bring under consideration how
therapeutic strategies now in use or under development for
neuropathic pain might be applied to painful or potentially
painful endometriosis [32,33].
Besides endometriosis, our results have relevance to another,
seemingly unrelated clinical situation: tissue/organ transplanta-
tion. Due to their removal from the donor, all donor tissues and
organs are denervated before transplantation. The question
therefore arises as to the importance of re-innervation for the
health and proper functioning of the transplanted organ, as well as
the possibility, raised here, that such re-innervation could give rise
to neuropathic-type pain. The topic has not been extensively
studied. Some evidence exists for re-innervation of the auto-
transplanted heart and syngeneically-transplanted kidney in
experimental animals [34,35]. Most studies in humans of re-
innervation of transplanted organs (necessarily allogenic) generally
indicate that there is limited sympathetic fiber re-innervation by a
year or more after transplant [36,37]. Debate about the
importance of this re-innervation for healthy organ functioning
continues, but is generally supportive [38]. Some findings also
suggest limited sensory fiber re-innervation, as evidenced by the
fact that pain can be provoked by cardiac ischemia in heart
transplant patients [39] or lobeline injections in lung transplant
patients [40]. The issue of whether either chronic pain or co-
morbidity develops after transplant, is, however, complicated by
the lifetime cocktail of neurotoxic immunosuppressant and other
drugs that patients must take [41]. Nevertheless, the very limited
evidence so far seems to suggest that re-innervation may be a more
significant factor for uterine transplants or ectopic endometrial
growths than it is for other organs. One contributing feature may
be the hormonal susceptibility of the innervation of the uterine or
ectopic endometrial growths. Thus, sympathetic innervation
density of the ectopic uterine growths varies with estrous stage
[15]. Furthermore, others have shown in both rodents and
humans that innervation of the healthy uterus also undergoes
anatomical changes during the ovarian cycle as well as significant
changes during pregnancy [42]. Despite considerable research on
hormonal influences on the physiological functioning of other
organs, however, little is known about such anatomical changes in
innervation of other tissues. Together, these considerations
indicate the potential translational value of future studies aimed
at comparing the re-innervation and consequences of that re-
innervation in different transplanted organs in males and females.
Materials and Methods
Ethics Statement
The studies were carried out in strict accordance with the
recommendations in the Guide for the Care and Use of
Laboratory Animals of the National Institutes of Health. The
protocol was approved by the Florida State University’s Animal
Care and Use Committee as protocol # 9028. All recovery
surgery was performed under ketamine/xylazine anesthesia.
Urethane anesthesia was used for terminal procedures. All efforts
were made to minimize suffering.
Animals
Female Sprague-Dawley rats who weighed 175–225 g at the
beginning of the study were used. Rats were housed individually in
a temperature-controlled room (22.2uC) in plastic cages lined with
chip bedding, with ad libitum access to rat chow and water, and
maintained on a 12-h light/dark cycle, with lights on at 07:00 AM.
Estrous stage determination
Estrous stage was determined by daily vaginal lavage performed
approximately 2 h after lights on for all rats. Traditional
nomenclature was used [43]. All rats maintained regular four-
day estrous cycles throughout the study.
Figure 2. Evans Blue dye extravasation in intact and denervat-
ed cysts harvested at different times after transplant surgery.
Note that the cysts’ sensory innervation becomes functional (i.e.,
contributes to EB dye extravasation) three weeks after transplant
surgery, which is one week before the hyperalgesia becomes significant
(Fig. 1A). *, differs from intact at the same time period, p#0.05. Within
the Intact group: #, differs from the one-week time period, (p#0.05).
Error bars are 6 SEM (n=8–12/group).
doi:10.1371/journal.pone.0031758.g002
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Rats in metestrus or diestrus were anesthetized i.p. with a
mixture of ketamine hydrochloride (73 mg/kg) and xylazine
(8.8 mg/kg). Following aseptic precautions, an abdominal incision
was made to expose the uterus and a 1–1.25 cm segment of the left
uterine horn and associated fat tissue were removed and placed in
warm saline. Four approximately equally-sized pieces of uterine
horn (as close as possible to 2 mm62 mm) were cut from this
segment. Beginning at the caecum, these pieces of uterine horn
were sewn on alternate cascading mesenteric arteries that supply
the small intestine. After assuring hemostasis, the incision was
sutured closed in layers, and butorphanol given (1 mg/kg, s.c.) as
necessary. Rats were not tested behaviorally for the first post-
operative week after surgery.
Surgical cyst removal or sham-cyst removal
Rats in which transplant surgery had occurred 1 to 4 weeks
earlier and were in diestrus, metestrus, or estrus, were anesthetized
and abdominal organs exposed as for the original transplant
surgery. The caecum was located and the transplants identified.
Each cyst was carefully freed from surrounding fat and connective
tissue and measured. Cysts were either removed completely
(including the suture) with Castroviejo micro-dissecting scissors
and a fine-tipped cautery (n=8 rats), or, for sham-cyst removal,
left in place (n=4 rats). Post-operative procedures were the same
as for the endometriosis surgery.
Behavioral testing procedures
All behavioral training and testing was done between 3 and 8 h
after lights on using techniques described previously [44]. Briefly,
rats were first trained to terminate (‘‘escape’’ from) vaginal distention
produced by an inflatable balloon. The vaginal distention was
produced by inflating a latex balloon (10 mm long61.5 mm wide
when uninflated) tied to a thin catheter with silk suture. The
uninflated balloon was lubricated (K-Y jelly) and inserted into the
mid-vaginal canal, located so that it would not touch the cervix even
when inflated. Inflating the balloon with different volumes of water
using a computer-controlled pump distended the vaginal canal. The
pressure produced by each volume of distention (corrected for
compliance characteristics of the balloon) was measured through a
small-volume Cobe pressure transducer. After rats were trained to
maketheescape response,sessionsto assessvaginal nociception were
begun. During each assessment session, eight distention volumes
were delivered three times each in random order at 60615 sec
intervals. Test sessions were run 3–4 times/wk on non-consecutive
days. Testing sessions in each of the two assessment periods included
at least 3 days in each estrous stage. Here, we show data obtained
during proestrus, the stage in which the severity of vaginal
hyperalgesia or referred muscle hyperalgesia is greatest [7–9].
Experimental and control groups for the two behavioral
studies
The first behavioral study assessed the time course of the
development of vaginal hyperalgesia after transplant surgery in 10
Figure 3. Effect of cyst removal or sham-cyst removal
performed before the cysts acquire mature innervation on
the development of vaginal hyperalgesia. A. This diagram depicts
the time-course of experimental testing (baseline, post-transplant) and
surgical procedures (1, 2 or 4 weeks after transplant). B–D. The graphs
show percent escape response as a function of vaginal distention
volume before (baseline, solid line) and 5–10 weeks after transplant
surgery (dashed line). Error bars are 6 SEM. The inset bar graphs depict
the severity of hyperalgesia individually for each rat in that group (as in
Fig. 1). Solid bars indicate cyst removal or sham-cyst removal at 1 or 2
weeks post-transplant; the hatched bars indicate cyst removal or sham-
cyst removal at 4 weeks post-transplant. B. Pre-innervation cyst removal
(1 or 2 weeks post-transplant) prevents the development of hyperal-
gesia (n=5). C. When cyst removal is performed just after innervation
has become active, but before innervation is mature; i.e., 4 weeks post-
transplant, the development of hyperalgesia is prevented in two of
three rats. D. In contrast, after sham-cyst removal, regardless of when
the surgery is performed relative to the innervation (either 2 or 4 weeks
after transplant), hyperalgesia develops in all rats (n=4).
doi:10.1371/journal.pone.0031758.g003
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proestrus for 6–8 weeks before surgery to establish a baseline, then
after transplant surgery for 12 weeks. The second behavioral study
assessed the effects of removing the cysts prior to the development
of functional innervation or the development of significant
hyperalgesia (i.e., 1–4 weeks after transplant surgery) in eight rats.
As a control, a sham cyst-removal surgery was performed in 4 rats
during this same period. In this second study, vaginal nociception
was calculated for 6–8 weeks before transplant surgery to establish
a baseline then, after cyst-removal or sham cyst-removal surgery,
for an additional 10 weeks.
Calculation of vaginal nociception and hyperalgesic
severity
Calculations were identical to those used in previous studies [9].
For each rat, the percent escape response to each distention
volume was assessed in each session and averaged for each
chronological test period. This procedure produced a graph of the
percent escape response as a function of distention volume for
each test period (Fig. 3). For each graph, an area-under-the-curve
(AUC) calculation was performed using standard methods. The
AUC calculation yielded a single value that described vaginal
nociception during that test period.
In the first behavioral study (Fig. 1A), testing periods included
the baseline period before transplant surgery and then weekly
periods for 12 weeks post-transplant. The severity of vaginal
hyperalgesia that developed after transplant surgery (i.e., the post-
transplant change in vaginal nociception) was quantified by
subtracting the baseline (pre-transplant) AUC value from each of
the post-transplant AUC values at weekly time points, beginning
with the second week. No data are available for the first post-
transplant week because rats were not testing during this recovery
period. The severity values were averaged across rats for each time
point. Statistical assessment included a one-way ANOVA, which
was significant (F10,72=4.37, p,0.001), and therefore followed by
post-hoc LSD tests, with significance set at p#0.05).
In the second behavioral study (Fig. 3B, 3C), there were two
test periods (Fig. 3A): baseline (pre-transplant) and one post-
transplant period that included the time from 5–10 weeks after
transplant. Graphs of escape response as a function of volume
were averaged across rats in each group (cyst removal group
versus sham cyst removal group) for each test period (pre-
transplant baseline and post-transplant). These data were
statistically analyzed by a three-way repeated measure ANOVA
(distention volume, test period, cyst surgery type), which was
significant (F31,160=150.52, p,0.001), with significant (p,0.05)
effects of volume, pre- versus post-transplant test period, surgical
group, and all interactions (volume*test period; volume*surgery
group; test period*surgery group, and volume*test period*-
surgical group). AUC vaginal nociception values for each surgical
group and test period were also averaged across rats. The AUC
values were statistically analyzed by a two-way ANOVA (surgical
group, test period), which was also significant (F3,20=10.02,
p,0.001), with significant effects of test period (p,0.001), surgical
group (p=0.028), and the interaction between test period and
surgical group (p=0.001). This overall significance pattern
regardless of outcome measure (% escape or AUC) justified
additional ANOVAs as appropriate, which were done using the
AUC values.
Immunostaining
Under urethane anesthesia (1.2 g/kg), rats in proestrus at 2, 3,
4, 6, or 10 weeks after transplant surgery (n=3 to 5 rats at each
survival time) were perfused with 4% paraformaldehyde. Cysts
were harvested, post-fixed in 4% paraformaldehyde for 1 h and
then incubated in 30% sucrose overnight. Cysts were embedded
in Tissue-Tek Oct compound, frozen, cut serially in 20 mm-thick
sections using a cryostat, and mounted on slides in 10 sets of
sections (i.e., sections on a slide were separated by 200 mm).
Adjacent sections from the same cysts were treated with 5%
normal goat serum (NGS) for 1 h, then were immunolabeled with
one of the two rabbit primary antibodies: either a marker for
sensory C- fibers, calcitonin gene related peptide (CGRP,
1:4,000; Chemicon, CA) or for sympathetic fibers, vesicular
monoamine transporter 2 (VMAT2, 1:1,000; Chemicon, CA)
including 2% NGS at 4uC overnight. Sections were then
incubated for 1.5 h with goat anti-rabbit Cy2-conjugated
secondary antibody (1:300, Jackson ImmunoResearch lab, PA).
Negative controls were routinely performed for each immuno-
staining run; they included omission of the primary or the
secondary antibody or both. No immunostaining of nerve fibers
was evident in these controls. All immunostained sections were
carefully examined using an epifocal microscope, and fiber
labeling, if any, noted and qualitatively characterized. The
representative sections shown here were photographed using an
Optronics Microfire camera (Optronics International, Chelms-
ford, MA), and the entire image adjusted for contrast and
brightness.
Functionality of C-fiber innervation of the cysts
The Evans Blue dye (EB) extravasation method was used to
assess neurogenic activity in intact and denervated cysts in rats at
1, 2, 3, 4, 6, or 10 weeks after ENDO surgery [13] (n=8–12 rats
for each survival time and each innervation class; i.e., intact or
denervated). Previously, we observed that sensory fibers and
postganglionic neurons for the sympathetic fibers that sprout into
the cysts are located in the splanchnic nerve and coeliac ganglion,
respectively [45]. Cyst denervation, therefore, involved removing
these sources of innervation.
All rats were in proestrus on the day of the experiment for the 1-
through 6-week survival time. We only had data at the 10 week-
survival time from rats in metestrus. We thought it reasonable to
include these 10-week data here, however, so a more complete
comparison with the behavioral data shown in Figure 1 could be
made, and because rats in metestrus, like those in proestrus,
evidence vaginal hyperalgesia; i.e., the biggest difference in
severity of hyperalgesia is between proestrus and estrus [7]. Rats
were first anesthetized with urethane (1.2 g/kg) and placed on a
warm heating pad (maintained as close as possible to 37u C). In the
rats scheduled for cyst denervation, a laparotomy was performed
to expose the splanchnic nerve and coeliac ganglion. The
splanchnic nerve was identified and cut rostral to the coeliac
ganglion, and the ganglion itself was carefully denervated by
cutting all nerves associated with it. The abdominal muscles and
skin were sutured, after which EB was injected. For EB injections,
the jugular vein was exposed through an incision and catheterized.
EB (50 mg/kg in saline) was then delivered through the catheter.
Thirty min later, excess dye was rinsed out of blood vessels by
delivering 200 ml of saline through the catheter. Cysts were
harvested, weighed, and incubated in formamide at 60u C for
48 h. Optical density of the sample and standard solutions was
measured spectrophotometrically (l=620 nm, UV: 1601; Shi-
madzu, Columbia, MD). The amount of EB extracted from each
sample was calculated as mg EB/g of tissue. Because a two-way
ANOVA was significant (F11,120=2.44, p=0.009), data were
analyzed by post-hoc unpaired t-tests, with significance set at
p#0.05.
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